Search results
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
Digital Journal· 12 hours agoImmunotherapy, the latest technology in the war on cancer, can come in various forms; including: checkpoint inhibitors, ...
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs - Indianapolis...
Indianapolis Business Journal· 2 days agoEli Lilly and Co. and a biopharma company it bought last year are accused of infringing on the...
340B drug program spending up 19% + 6 other notes
Becker’s Hospital Review· 17 hours agoEstablished by Congress in 1992, the 340B drug pricing program allows qualifying hospitals and clinics that treat low-income and uninsured patients to purchase some drugs ...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 9 hours agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell...
Study reveals unexpected mechanism of drug resistance in kidney cancer
Medical Xpress· 6 days agoFor nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Published in the Proceedings of the National Academy of ...
Combined immunotherapy drugs ‘could treat most common form of bowel cancer’
PA Media: Science via Yahoo News· 5 days agoA combination of two immunotherapy drugs could be used to treat the most common form of bowel cancer...
...Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to...
Digital Journal· 10 hours agoCHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals
Morningstar· 17 hours agoAstraZeneca said a late-stage study showed that its therapy for advanced or metastatic triple-negative breast cancer didn't meet its primary goals. The British-Swedish pharma ...
Cancer disappears in 100% of patients treated with new drug in promising clinical trial
Euronews via Yahoo News· 7 days agoA study showed a 100 per cent positive response rate in 42 patients with a specific type of rectal ...
Merck Get FDA Approval for Keytruda to Treat Endometerial Cancer
Morningstar· 1 day agoMerck said its blockbuster cancer drug Keytruda has been approved for the treatment of adult patients with primary advanced or recurrent endometrial carcinoma ...